Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical and parasitological efficacy over 42 days of artesunate-pyronaridine in the treatment of uncomplicated falciparum malaria in 2 provinces in Cambodia

Trial Profile

Clinical and parasitological efficacy over 42 days of artesunate-pyronaridine in the treatment of uncomplicated falciparum malaria in 2 provinces in Cambodia

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jan 2019

At a glance

  • Drugs Artesunate/pyronaridine (Primary) ; Primaquine
  • Indications Falciparum malaria
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jan 2019 Results published in the Antimicrobial Agents and Chemotherapy
    • 13 Aug 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top